PD-Rx Pharmaceuticals, Inc. (PDRX)

Market Cap	4.52M
Revenue (ttm)	18.95M
Net Income (ttm)	-753.50K
Shares Out	1.64M
EPS (ttm)	-0.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,588
Average Volume	1,949
Open	2.750
Previous Close	n/a
Day's Range	2.410 - 2.750
52-Week Range	2.410 - 5.000
Beta	1,396,314.39
RSI	39.10
Earnings Date	Dec 6, 2024

About PD-Rx Pharmaceuticals

PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, including creams, ointments, ophthalmics, otics, liquids, and suspensions products. It also provides packaging services. In addition, the company offers dispensing platform, a manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as handling package; and PD-Rx Net, a web-based application designed to track...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1986
• Employees: 28
• Stock Exchange: OTCMKTS
• Ticker Symbol: PDRX

Financial Performance

In 2024, PD-Rx Pharmaceuticals's revenue was $18.95 million, a decrease of -10.93% compared to the previous year's $21.27 million. Losses were -$753,495, 668.4% more than in 2023.